S&P 500   3,298.46 (+1.60%)
DOW   27,173.96 (+1.34%)
QQQ   271.56 (+2.32%)
AAPL   112.28 (+3.75%)
MSFT   207.82 (+2.28%)
FB   254.82 (+2.12%)
GOOGL   1,439.06 (+1.14%)
AMZN   3,095.13 (+2.49%)
TSLA   407.34 (+5.04%)
NVDA   514.95 (+4.26%)
BABA   271.09 (+0.50%)
CGC   14.17 (-0.70%)
GE   6.11 (+0.99%)
MU   49.14 (-0.67%)
AMD   78.06 (+2.95%)
T   28.04 (+0.00%)
F   6.51 (-2.25%)
ACB   5.05 (-2.88%)
GILD   62.25 (+0.00%)
NFLX   482.88 (+2.07%)
DIS   124.00 (+1.23%)
BAC   23.49 (+0.64%)
BA   156.03 (+6.83%)
S&P 500   3,298.46 (+1.60%)
DOW   27,173.96 (+1.34%)
QQQ   271.56 (+2.32%)
AAPL   112.28 (+3.75%)
MSFT   207.82 (+2.28%)
FB   254.82 (+2.12%)
GOOGL   1,439.06 (+1.14%)
AMZN   3,095.13 (+2.49%)
TSLA   407.34 (+5.04%)
NVDA   514.95 (+4.26%)
BABA   271.09 (+0.50%)
CGC   14.17 (-0.70%)
GE   6.11 (+0.99%)
MU   49.14 (-0.67%)
AMD   78.06 (+2.95%)
T   28.04 (+0.00%)
F   6.51 (-2.25%)
ACB   5.05 (-2.88%)
GILD   62.25 (+0.00%)
NFLX   482.88 (+2.07%)
DIS   124.00 (+1.23%)
BAC   23.49 (+0.64%)
BA   156.03 (+6.83%)
S&P 500   3,298.46 (+1.60%)
DOW   27,173.96 (+1.34%)
QQQ   271.56 (+2.32%)
AAPL   112.28 (+3.75%)
MSFT   207.82 (+2.28%)
FB   254.82 (+2.12%)
GOOGL   1,439.06 (+1.14%)
AMZN   3,095.13 (+2.49%)
TSLA   407.34 (+5.04%)
NVDA   514.95 (+4.26%)
BABA   271.09 (+0.50%)
CGC   14.17 (-0.70%)
GE   6.11 (+0.99%)
MU   49.14 (-0.67%)
AMD   78.06 (+2.95%)
T   28.04 (+0.00%)
F   6.51 (-2.25%)
ACB   5.05 (-2.88%)
GILD   62.25 (+0.00%)
NFLX   482.88 (+2.07%)
DIS   124.00 (+1.23%)
BAC   23.49 (+0.64%)
BA   156.03 (+6.83%)
S&P 500   3,298.46 (+1.60%)
DOW   27,173.96 (+1.34%)
QQQ   271.56 (+2.32%)
AAPL   112.28 (+3.75%)
MSFT   207.82 (+2.28%)
FB   254.82 (+2.12%)
GOOGL   1,439.06 (+1.14%)
AMZN   3,095.13 (+2.49%)
TSLA   407.34 (+5.04%)
NVDA   514.95 (+4.26%)
BABA   271.09 (+0.50%)
CGC   14.17 (-0.70%)
GE   6.11 (+0.99%)
MU   49.14 (-0.67%)
AMD   78.06 (+2.95%)
T   28.04 (+0.00%)
F   6.51 (-2.25%)
ACB   5.05 (-2.88%)
GILD   62.25 (+0.00%)
NFLX   482.88 (+2.07%)
DIS   124.00 (+1.23%)
BAC   23.49 (+0.64%)
BA   156.03 (+6.83%)
Log in
NASDAQ:ECOR

electroCore Stock Forecast, Price & News

$1.61
-0.03 (-1.83 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.56
Now: $1.61
$1.68
50-Day Range
$1.43
MA: $1.80
$2.27
52-Week Range
$0.32
Now: $1.61
$3.30
Volume452,125 shs
Average Volume2.69 million shs
Market Capitalization$71.69 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81
electroCore, Inc., a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, which is a handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ECOR
CUSIPN/A
CIKN/A
Phone973-290-0097

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.39 million
Book Value$0.84 per share

Profitability

Net Income$-45,150,000.00
Net Margins-1,120.81%

Miscellaneous

Employees51
Market Cap$71.69 million
Next Earnings Date11/11/2020 (Estimated)
OptionableNot Optionable
$1.61
-0.03 (-1.83 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ECOR News and Ratings via Email

Sign-up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











electroCore (NASDAQ:ECOR) Frequently Asked Questions

How has electroCore's stock price been impacted by Coronavirus (COVID-19)?

electroCore's stock was trading at $0.5874 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ECOR shares have increased by 174.1% and is now trading at $1.61.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of electroCore?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for electroCore in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for electroCore
.

When is electroCore's next earnings date?

electroCore is scheduled to release its next quarterly earnings announcement on Wednesday, November 11th 2020.
View our earnings forecast for electroCore
.

How were electroCore's earnings last quarter?

electroCore, Inc. (NASDAQ:ECOR) posted its quarterly earnings data on Thursday, August, 13th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.17) by $0.04. The business had revenue of $0.75 million for the quarter. electroCore had a negative net margin of 1,120.81% and a negative return on equity of 131.02%.
View electroCore's earnings history
.

What guidance has electroCore issued on next quarter's earnings?

electroCore issued an update on its second quarter 2020 After-Hours earnings guidance on Tuesday, July, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $730K - 750K, compared to the consensus revenue estimate of $890K.

What price target have analysts set for ECOR?

6 analysts have issued 1-year price objectives for electroCore's shares. Their forecasts range from $2.00 to $9.00. On average, they expect electroCore's stock price to reach $4.30 in the next year. This suggests a possible upside of 167.1% from the stock's current price.
View analysts' price targets for electroCore
.

Are investors shorting electroCore?

electroCore saw a decrease in short interest in August. As of August 31st, there was short interest totaling 1,020,000 shares, a decrease of 12.8% from the August 15th total of 1,170,000 shares. Based on an average daily trading volume, of 5,580,000 shares, the short-interest ratio is currently 0.2 days.
View electroCore's Short Interest
.

Who are some of electroCore's key competitors?

What other stocks do shareholders of electroCore own?

Based on aggregate information from My MarketBeat watchlists, some companies that other electroCore investors own include Heat Biologics (HTBX), T2 Biosystems (TTOO), Acasti Pharma (ACST), Vaxart (VXRT), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), BioNano Genomics (BNGO), Matinas BioPharma (MTNB), Onconova Therapeutics (ONTX) and Canopy Growth (CGC).

Who are electroCore's key executives?

electroCore's management team includes the following people:
  • Mr. Daniel S. Goldberger, CEO & Director (Age 61, Pay $187.5k)
  • Mr. Joseph P. Errico, Co-Founder, Principal Investor & Director (Age 51, Pay $776.28k)
  • Mr. Brian M. Posner, CFO & Corp. Sec. (Age 58, Pay $380.54k)
  • Dr. Peter S. Staats, Chief Medical Officer (Age 56, Pay $238.41k)
  • Mr. Michael Romaniw, VP of Operations, Systems & Logistics (Age 63)

When did electroCore IPO?

(ECOR) raised $64 million in an initial public offering on Friday, June 22nd 2018. The company issued 4,300,000 shares at $14.00-$16.00 per share. Evercore ISI and JMP Securities served as the underwriters for the IPO and BTIG was co-manager.

What is electroCore's stock symbol?

electroCore trades on the NASDAQ under the ticker symbol "ECOR."

Who are electroCore's major shareholders?

electroCore's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Jane Street Group LLC (0.16%) and Verition Fund Management LLC (0.08%). Company insiders that own electroCore stock include Brian M Posner, Carrie Smith Cox, Francis R Amato, James L L Tullis, Joseph P Errico, Peter S Staats and Thomas J Errico.
View institutional ownership trends for electroCore
.

Which institutional investors are buying electroCore stock?

ECOR stock was purchased by a variety of institutional investors in the last quarter, including Jane Street Group LLC, and Verition Fund Management LLC. Company insiders that have bought electroCore stock in the last two years include Brian M Posner, Carrie Smith Cox, Francis R Amato, James L L Tullis, Peter S Staats, and Thomas J Errico.
View insider buying and selling activity for electroCore
.

How do I buy shares of electroCore?

Shares of ECOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is electroCore's stock price today?

One share of ECOR stock can currently be purchased for approximately $1.61.

How big of a company is electroCore?

electroCore has a market capitalization of $71.69 million and generates $2.39 million in revenue each year. The company earns $-45,150,000.00 in net income (profit) each year or ($1.54) on an earnings per share basis. electroCore employs 51 workers across the globe.

What is electroCore's official website?

The official website for electroCore is www.electrocore.com.

How can I contact electroCore?

electroCore's mailing address is 150 ALLEN ROAD SUITE 201, BASKING RIDGE NJ, 07920. The company can be reached via phone at 973-290-0097 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.